Compounds > cp-55,940
Page last updated: 2024-08-26

cp-55,940 and N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide

cp-55,940 has been researched along with N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, JG; Babij, P; Fotsch, C1

Reviews

1 review(s) available for cp-55,940 and N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide

ArticleYear
Emerging targets in osteoporosis disease modification.
    Journal of medicinal chemistry, 2010, Jun-10, Volume: 53, Issue:11

    Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis

2010